A photo of Xueheng Zhao.

Xueheng Zhao, PhD


  • Member, Division of Pathology and Laboratory Medicine
  • Assistant Professor, UC Department of Pediatrics

About

Biography

I'm a bioanalytical chemist. My laboratory work using mass spectrometry includes three complementary themes: metabolism, metabolomics and clinical chemistry. My lab develops new tools that support solving biological questions through collaboration with clinicians and basic scientists. We are developing analytical methodologies tailored to biomarker discovery, particularly in the early diagnosis and treatment of pediatric genetic disorders, lysosomal storage and liver diseases. Additionally, my group engineers bioinformatic tools designed for lipidomic and metabolomics projects to enhance batch effect correction, metabolite identification and network analysis.

As a graduate student at the University of Georgia, I used ion trap mass spectrometry to determine biodegradation products from potentially carcinogenic azo dyes by microorganisms. I was amazed by mass spectrometry’s capability to measure metabolites sensitively and quantitatively and uncover unknown biological pathways. This led to my continued interest in mass spectrometry-based research.

Metabolic reprogramming and perturbation by genetic and environmental factors are key characteristics of cancer and metabolic diseases, including neurofibromatosis (NF) and metabolic dysregulation-associated fatty liver disease (MAFLD). A primary interest of my research is using mass spectrometry and -omics approach to discover novel biomarkers and dysregulated metabolic pathways to improve treatment for these refractory diseases.

My research uses lipidomics profiling to discover the metabolic links of the Fanconi anemia (FA) pathway and glycosphingolipid metabolism in head and neck cancer cells, published in Clinical Cancer Research. I also identified distinct bile acid signatures in undernourished children with environmental enteric dysfunction (EED), published in the Journal of Nutrition.

I'm honored to have been awarded a National Library of Medicine Fellowship at Stanford University. I have been a researcher for over 20 years and began working at Cincinnati Children's in 2007.

Interests

Lipidomics and metabolomics; mass spectrometry; metabolism

Research Areas

Publications

Advancing Clinical and Pathophysiological Insights into Pancreatitis Using Lipidomics and Metabolomics. Ahmed, F; Zhao, X; Setchell, KD R; Abu-El-Haija, M. Metabolites. 2025; 15:666.

Central Roles of Glucosylceramide in Driving Cancer Pathogenesis. Zhao, X; Pandey, MK. International Journal of Molecular Sciences. 2025; 26:9879.

Acute pancreatitis gut dysbiosis persists at 1-year follow-up and is associated with clinical outcomes. Dike, CR; Duan, Q; Ahmed, F; Denson, LA; Haslam, D; Minar, P; Ollberding, NJ; Papachristou, GI; Setchell, KD R; Thompson, T; Vitale, DS; Zhao, X; Abu-El-Haija, M. Journal of Pediatric Gastroenterology and Nutrition. 2025; 81:690-698.

The Fanconi Anemia Pathway Inhibits mTOR Signaling and Prevents Accelerated Translation in Head and Neck Cancer Cells. Ruffolo, B; Vicente-Muñoz, S; Mehta, KY; Rivera-Cruz, CM; Zhao, X; Romick, L; Setchell, KD R; Lane, A; Wells, SI. Cancers. 2025; 17:2583.

Volumetric Absorptive Microsampling Combined with Mass Spectrometry to Support Pharmacokinetically-Guided Precision Dosing of Mycophenolate Mofetil in Pediatric Lupus Nephritis Patients. Zhao, J; Zhao, X; Mizuno, T; Irie, K; Devarajan, P; Brunner, HI; Setchell, KD R. The journal of applied laboratory medicine. 2025; 10:806-819.

Microbial metabolite drives ageing-related clonal haematopoiesis via ALPK1. Agarwal, P; Sampson, A; Hueneman, K; Choi, K; Jakobsen, NA; Uible, E; Ishikawa, C; Yeung, J; Bolanos, L; Zhao, X; Galloway-Pena, J; Byrd, JC; Vyas, P; Starczynowski, DT. Nature. 2025; 642:201-211.

Sa1442: LIPIDOMIC AND METABOLOMIC INSIGHTS INTO PEDIATRIC CHRONIC PANCREATITIS: DECIPHERING THE METABOLIC LANDSCAPE. Ahmed, F; Zhao, X; Beres, R; Garlapally, V; Mouzaki, M; Setchell, KD; Husain, SZ; Abu-El-Haija, M. Gastroenterology. 2025; 169:s-471.

Dihydroxyacetone phosphate is a novel predictor of hepatic fibrosis in Latino adolescents with obesity. Schenker, RB; Ramirez, CB; Jang, C; Allayee, H; Zhao, X; Setchell, KD R; Kohli, R; Goran, MI. Journal of Pediatric Gastroenterology and Nutrition. 2025; 80:174-181.

Inhibition of RHOA activity preserves the survival and hemostasis function of long-term cold-stored platelets. Hegde, S; Akbar, H; Wellendorf, AM; Nestheide, S; Johnson, JF; Zhao, X; Setchell, KD; Zheng, Y; Cancelas, JA. Blood. 2024; 144:1732-1746.

Machine-learning-based integrative -'omics analyses reveal immunologic and metabolic dysregulation in environmental enteric dysfunction. Zulqarnain, F; Zhao, X; Setchell, KD R; Sharma, Y; Fernandes, P; Srivastava, S; Shrivastava, A; Ehsan, L; Jain, V; Raghavan, S; Brown, DE; Moore, SR; Ali, SA; Syed, S. iScience. 2024; 27:110013.